| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| C468971-250mg | 250mg | 2 | $85.90 | |
| C468971-1g | 1g | 2 | $279.90 |
| Synonyms | cis-Dichlorobis(dimethylsulfoxido)platinum(II) | Pt(DMSO)2Cl2 |
|---|---|
| Specifications & Purity | ≥97% |
| Storage Temp | Room temperature,Argon charged |
| Shipped In | Normal |
| Product Description | cis-Dichlorobis(dimethyl sulfoxide)platinum(II) is a platinum complex used as a catalyst in various chemical reactions, including the methylation of polyfluorinated aryl imines and methane oxidation. It is identified as an effective C-F activation precatalyst. Application： cis-Dichlorobis(dimethyl sulfoxide)platinum(II) can be used as a:
Catalyst in the oleum-mediated (SO3-H2SO4) methane oxidation to form methyl bisulfate (MBS).
Precursor in the synthesis of cyclometalated complexes.
|
| Pubchem Sid | 504762363 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504762363 |
| IUPAC Name | methylsulfinylmethane;platinum(2+);dichloride |
| INCHI | InChI=1S/2C2H6OS.2ClH.Pt/c2*1-4(2)3;;;/h2*1-2H3;2*1H;/q;;;;+2/p-2 |
| InChi Key | KDADQDWVKZJTDQ-UHFFFAOYSA-L |
| Canonical SMILES | CS(=O)C.CS(=O)C.[Cl-].[Cl-].[Pt+2] |
| Isomeric SMILES | CS(=O)C.CS(=O)C.[Cl-].[Cl-].[Pt+2] |
| PubChem CID | 3035418 |
| Molecular Weight | 422.25 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 J2417266 | Certificate of Analysis | Oct 14, 2024 | C468971 |
| J2417267 | Certificate of Analysis | Oct 14, 2024 | C468971 |
| J2417268 | Certificate of Analysis | Oct 14, 2024 | C468971 |
| B2427386 | Certificate of Analysis | Jan 22, 2024 | C468971 |
| B2427396 | Certificate of Analysis | Jan 22, 2024 | C468971 |
| B2427398 | Certificate of Analysis | Jan 22, 2024 | C468971 |
| B2427412 | Certificate of Analysis | Jan 22, 2024 | C468971 |
| Pictogram(s) | GHS07 |
|---|---|
| Signal | Warning |
| Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
| Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
| RIDADR | NONH for all modes of transport |
| 1. A Yamaguchi,Y Tsukioka,S Fushida,Y Kurosaka,M Kanno,Y Yonemura,K Miwa,I Miyazaki. (1992-10-01) Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers.. Diseases of the colon and rectum, 35 ((10)): (964-968). [PMID:1395984] |
| 2. R L Page,D E Thrall,S L George,G S Price,G L Heidner,M C McEntee,C A Novotney,M L Hauck,M W Dewhirst. (1992-11-01) Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs.. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 8 ((6)): (761-769). [PMID:1479202] |
| 3. S Masunaga,K Ono,M Abe. (1992-01-01) Potentially lethal damage repair by quiescent cells in murine solid tumors.. International journal of radiation oncology, biology, physics, 22 ((5)): (973-978). [PMID:1555989] |
| 4. S Hayashi,H Ogino,K Ogata,K Yagawa. (1992-01-01) Hypercoagulopathy induced by chemotherapy in a patient with lung cancer. A possible role for a factor with thrombosis-inducing activity (TIA).. Chest, 101 ((1)): (277-278). [PMID:1729088] |
| 5. J L Schwartz,J Tanaka,V Khandekar,T S Herman,B A Teicher. (1992-01-01) Beta-carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells.. Cancer chemotherapy and pharmacology, 29 ((3)): (207-213). [PMID:1733553] |
| 6. M Imaizumi,T Kondo,T Taguchi,T Hattori,O Abe,M Kitano,A Wakui. (1993-01-01) A standardized method of using nude mice for the in vivo screening of antitumor drugs for human tumors.. Surgery today, 23 ((5)): (412-419). [PMID:8324334] |
| 7. B A Teicher,D Chatterjee,J T Liu,S A Holden,G Ara. (1993-01-01) Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors.. Cancer chemotherapy and pharmacology, 32 ((4)): (315-319). [PMID:8324874] |
| 8. J A Gondal,H G Preuss,R Swartz,A Rahman. (1993-01-01) Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents.. European journal of cancer (Oxford, England : 1990), 29A ((11)): (1536-1542). [PMID:8217358] |
| 9. L Türkeri,Y Ilker,F Simşek,A Akdaş. (1993-01-01) Neoadjuvant (induction) chemotherapy in advanced bladder carcinoma.. International urology and nephrology, 25 ((3)): (259-263). [PMID:8225827] |
| 10. D A Corral,R R Bahnson. (1993-05-01) Treatment of pathological stage T3N+M0 bladder cancer: the case for observation.. Seminars in urology, 11 ((2)): (64-68). [PMID:8362121] |
| 11. P J Walther. (1993-05-01) Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.. Seminars in urology, 11 ((2)): (69-73). [PMID:8362122] |
| 12. A W Konings,J V Hettinga,W Lemstra,G B Humphrey,H H Kampinga. (1993-07-01) Sensitizing for cis-diamminedichloroplatinum(II) action by hyperthermia in resistant cells.. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 9 ((4)): (553-562). [PMID:8366305] |
| 13. H Nakagawa,T Fujita,S Izumimoto,Y Miyawaki,S Kubo,Y Nakajima,K Tsuruzono,K Kodama,M Higashiyama,O Doi. (1993-04-01) cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. II: Clinical effects.. Journal of neuro-oncology, 16 ((1)): (69-76). [PMID:8410145] |
| 14. K R Grigorian,N A Bagramian. (2011-03-30) [Influence of cis-[PtCl2(Me2SO)2] on the thermal denaturation of albumin].. Biofizika, 56 ((1)): (31-34). [PMID:21442882] |
| 15. Y Saijo,Y Nakai,J Saito,S Sugawara,S Suzuki,Y Numata,M Motomiya. (1992-01-01) Changes in serum erythropoietin levels during chemotherapy for lung cancer.. Chemotherapy, 38 ((5)): (281-285). [PMID:1286570] |
| 16. J D De Certaines,J Albrectsen,V A Larsen,X Xie,J Rygaard,O Henriksen. (1992-11-01) In vivo 31P magnetic resonance spectroscopy and 1H magnetic resonance imaging of human bladder carcinoma on nude mice: effects of tumour growth and treatment with cis-dichloro-diamine platinum.. In vivo (Athens, Greece), 6 ((6)): (611-616). [PMID:1296810] |
| 17. B D Cheson,R S Ungerleider. (1992-12-01) Clinical trials referral resource. High priority trials--III. Breast cancer.. Oncology (Williston Park, N.Y.), 6 ((12)): (46-50). [PMID:1334690] |
| 18. Y Hata,N Takada,F Sasaki,T Abe,H Hamada,H Takahashi,J Uchino,Y Tsukada. (1992-06-01) Immunotargeting chemotherapy for AFP-producing pediatric liver cancer using the conjugates of anti-AFP antibody and anti-tumor agents.. Journal of pediatric surgery, 27 ((6)): (724-727). [PMID:1380075] |
| 19. J M Bachaud,N Albin,C Gay,E Chatelut,M Benchalal,J M David,A Boneu,E Serrano,P Canal,N Daly-Schveitzer. (1994-03-01) [Concomitant association of radiotherapy and chemotherapy (CDDP 4-6 mg/m2/daily in continuous i.v. administration) in locally advanced ORL tumors].. Bulletin du cancer, 81 ((3)): (212-218). [PMID:7894129] |
| 20. K Isshiki,A Nakao,M Ito,M Hamaguchi,H Takagi. (1993-01-01) P-glycoprotein expression in hepatocellular carcinoma.. Journal of surgical oncology, 52 ((1)): (21-25). [PMID:8095077] |
| 21. A W Konings,J V Hettinga,H H Kampinga. (1993-01-01) Osteosarcoma in adolescents and young adults: new developments and controversies. Thermal chemosensitization of cDDP-resistant cells.. Cancer treatment and research, 62 (93-100). [PMID:8096764] |
| 22. R S Dewoskin,R L Page,J E Riviere. (1993-07-01) Kidney trace metal response to combined cisplatin (CDDP) and hyperthermia.. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 9 ((4)): (529-537). [PMID:8366303] |
| 23. K Nishio,Y Fujiwara,Y Miyahara,Y Takeda,T Ohira,N Kubota,S Ohta,Y Funayama,H Ogasawara,M Ohata. (1993-10-21) Cis-diamminedichloroplatinum(II) inhibits p34cdc2 protein kinase in human lung-cancer cells.. International journal of cancer, 55 ((4)): (616-622). [PMID:8406990] |
| 24. H Nakagawa,T Fujita,S Izumoto,S Kubo,Y Nakajima,K Tsuruzono,K Kodama,M Higashiyama,O Doi,T Hayakawa. (1993-04-01) cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. I. Distribution within the central nervous system after intravenous and intracarotid infusion.. Journal of neuro-oncology, 16 ((1)): (61-67). [PMID:8410144] |
| 25. R Gorodetsky,A Vexler,X Mou,B Kaufman,E Loewenthal. (1993-07-01) A sensitive noninvasive analysis of Pt in external tissues. Followup of Pt deposition following cisplatin treatment.. Medical physics, 20 ((4)): (1007-1012). [PMID:8413007] |
